Follow the Connect Biopharma Holdings Ltd share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €847k. The latest transaction was filed on 1 July 2026 (Attribution). Among the most active insiders: LIU JEAN I. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Connect Biopharma Holdings Ltd is a biopharmaceutical company focused on developing treatments for immunological diseases. It is listed on NASDAQ under the symbol CNCT.